Publication: 3805

Publication: 3805

A randomized trial of radium-223 (Ra-223) dichloride and cabozantinib in patients (pts) with advanced renal cell carcinoma (RCC) with bone metastases (RADICAL / Alliance A031801)

URL

Google Scholar

Citation:: 71

Meeting Instance:: KCRS 2022
Year:: 2022
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: No-Endpoint
Analysis:: Trial-Description-Only
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: Yes

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA180820, UG1CA233302 (ECOG-ACRIN); U10CA180888, UG1CA233340 (SWOG);

Corr. Author:
Authors:: Rana R. McKay Pamela Atherton Heather Jacene Veronique Marcotte Archana Ajmera Shiva Baghaie Janet Koball Tyler Zemla Ronald C. Chen Atish Choudhury Joshua M. Lang Suzanne Cole Mamta Parikh Tareq Al Baghdadi Young Kwok Alan Tan Himisha Beltran Daniel George Michael J. Morris Toni K. Choueiri

Networks:: CA249, KANSAS, LAPS-MA036, LAPS-NC010, LAPS-NY016, LAPS-TN008, LAPS-TX011, LAPS-WI020, MCRC, MD015

Study: Alliance-A031801
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: